496 related articles for article (PubMed ID: 1383622)
21. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.
Stone PH; Gratsiansky NA; Blokhin A; Huang IZ; Meng L;
J Am Coll Cardiol; 2006 Aug; 48(3):566-75. PubMed ID: 16875985
[TBL] [Abstract][Full Text] [Related]
22. Comparison of single doses of ketanserin and placebo in chronic stable angina.
Cameron HA; Cameron CM; Ramsay LE
Br J Clin Pharmacol; 1986 Jul; 22(1):114-6. PubMed ID: 2874825
[TBL] [Abstract][Full Text] [Related]
23. [Myocardial ischemia with stable angina pectoris: clinico-ergometric evaluation after the use of diltiazem].
Maranhão MF; de Castro I; Albanesi Filho FM; Bozza A; de Brito AX; Sbissa AS
Arq Bras Cardiol; 1992 Feb; 58(2):149-55. PubMed ID: 1307461
[TBL] [Abstract][Full Text] [Related]
24. Effects of the cardioselective beta-blocker metoprolol in angina pectoris. A subacute study with exercise tests.
Keyriläinen O; Uustialo A
Ann Clin Res; 1975 Dec; 7(6):433-41. PubMed ID: 2092
[TBL] [Abstract][Full Text] [Related]
25. The anti-ischemic mechanism of action of ranolazine in stable ischemic heart disease.
Stone PH; Chaitman BR; Stocke K; Sano J; DeVault A; Koch GG
J Am Coll Cardiol; 2010 Sep; 56(12):934-42. PubMed ID: 20828645
[TBL] [Abstract][Full Text] [Related]
26. [Effectiveness of depot diltiazem in stable effort angina: a double-blind study compared with placebo].
Baldi N; Guiducci U; Piccitto R
G Ital Cardiol; 1996 May; 26(5):527-32. PubMed ID: 8767776
[TBL] [Abstract][Full Text] [Related]
27. [Isradipine versus diltiazem in the treatment of stable effort angina pectoris: ergometric evaluation in a crossover double-blind study].
Perticone F; Borelli DA; Maio R; Costa R; Pugliese F; Torchia L; Caristo S; Mattioli PL
G Ital Cardiol; 1994 Nov; 24(11):1395-402. PubMed ID: 7828793
[TBL] [Abstract][Full Text] [Related]
28. Effect of calcium antagonists on exercise tests.
Lai C; Cherchi A; Onnis E; Solinas R; Lai G; Cherchi PA
J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S55-64. PubMed ID: 1282616
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial.
Wilson SR; Scirica BM; Braunwald E; Murphy SA; Karwatowska-Prokopczuk E; Buros JL; Chaitman BR; Morrow DA
J Am Coll Cardiol; 2009 Apr; 53(17):1510-6. PubMed ID: 19389561
[TBL] [Abstract][Full Text] [Related]
30. Combination of calcium channel blockers and beta blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. The Netherlands Working Group on Cardiovascular Research (WCN).
van der Vring JA; Daniëls MC; Holwerda NJ; Withagen PJ; Schelling A; Cleophas TJ; Hendriks MG
Angiology; 1999 Jun; 50(6):447-54. PubMed ID: 10378820
[TBL] [Abstract][Full Text] [Related]
31. Effects of ranolazine on exercise tolerance and angina frequency in patients with severe chronic angina receiving maximally-tolerated background therapy: analysis from the Combination Assessment of Ranolazine In Stable Angina (CARISA) randomized trial.
Sendón JL; Lee S; Cheng ML; Ben-Yehuda O;
Eur J Prev Cardiol; 2012 Oct; 19(5):952-9. PubMed ID: 22689417
[TBL] [Abstract][Full Text] [Related]
32. Diltiazem, nifedipine, and their combination in patients with stable angina pectoris: effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment.
Frishman W; Charlap S; Kimmel B; Teicher M; Cinnamon J; Allen L; Strom J
Circulation; 1988 Apr; 77(4):774-86. PubMed ID: 3280158
[TBL] [Abstract][Full Text] [Related]
33. A controlled trial with a novel anti-ischemic agent, ranolazine, in chronic stable angina pectoris that is responsive to conventional antianginal agents. Ranolazine Study Group.
Pepine CJ; Wolff AA
Am J Cardiol; 1999 Jul; 84(1):46-50. PubMed ID: 10404850
[TBL] [Abstract][Full Text] [Related]
34. Antianginal efficacy of carvedilol, a new beta-blocker with vasodilating action.
Jamal SM; Freedman SB; Thomson A; Carter G; Harris PJ; Kelly DT
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S141-6. PubMed ID: 2454361
[TBL] [Abstract][Full Text] [Related]
35. [Does captopril possess antianginal actions? An evaluation of its effects on myocardial ischemia by stress tests in patients with stable angina and normal ventricular function].
Poveda Sierra JJ; Berrazueta JR; Ochoteco A; Salas E
Rev Esp Cardiol; 1993 Oct; 46(10):642-7. PubMed ID: 8234999
[TBL] [Abstract][Full Text] [Related]
36. Effects of ivabradine and ranolazine in patients with microvascular angina pectoris.
Villano A; Di Franco A; Nerla R; Sestito A; Tarzia P; Lamendola P; Di Monaco A; Sarullo FM; Lanza GA; Crea F
Am J Cardiol; 2013 Jul; 112(1):8-13. PubMed ID: 23558043
[TBL] [Abstract][Full Text] [Related]
37. [Clinical efficacy of perhexiline maleate in stable angina pectoris (author's transl)].
Linkesch W; Glogar D; Niederberger M
Wien Klin Wochenschr; 1978 Sep; 90(16):598-603. PubMed ID: 695649
[TBL] [Abstract][Full Text] [Related]
38. Beneficial effects of high-dose diltiazem in patients with persistent effort angina on beta-blockers and nitrates: a randomized, double-blind, placebo-controlled cross-over study.
Boden WE; Bough EW; Reichman MJ; Rich VB; Young PM; Korr KS; Shulman RS
Circulation; 1985 Jun; 71(6):1197-205. PubMed ID: 2859931
[TBL] [Abstract][Full Text] [Related]
39. Combination of calcium channel blockers and beta-adrenoceptor blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. Netherlands Working Group on Cardiovascular Research (WCN).
Van Der Vring JA; Daniëls MC; Holwerda NJ; Withagen PJ; Schelling A; Cleophas TJ; Hendriks MG
Br J Clin Pharmacol; 1999 May; 47(5):493-8. PubMed ID: 10336572
[TBL] [Abstract][Full Text] [Related]
40. [Ranolazine--an additional anti-anginal drug].
Michels G; Kochanek M; Hoppe UC
Dtsch Med Wochenschr; 2010 Oct; 135(41):2037-40. PubMed ID: 20925013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
